Reversal of Barrett's esophagus with acid suppression and multipolar electrocoagulation: Preliminary results

R. E. Sampliner, M (Brian) Fennerty, H. S. Garewal

Research output: Contribution to journalArticle

154 Citations (Scopus)

Abstract

Background: Barrett's esophagus is a premalignant lesion for esophageal adenocarcinoma. This study tests the hypothesis that re-injury of the metaplastic epithelium in an acid-controlled environment will result in reversal of Barrett's to squamous epithelium. Methods: Patients with at least 2 cm of Barrett's esophagus were treated with omeprazole, and half the circumference of the Barrett's was treated with multipolar electrocoagulation (MPEC); the other half served as an internal control. After 6 months, the remaining Barrett's esophagus was treated with MPEC. Results: Twenty-four hour esophageal pH of less than 4 averaged 1.8% on a mean dose of 56 mg/day of omeprazole. Ten patients had visual and biopsy elimination of the targeted section of Barrett's esophagus after an average of 2.5 MPEC sessions. The remainder of the Barrett's esophagus is being treated in 9 patients; currently 5 have no evidence of Barrett's. Conclusions: The combination of control of esophageal acid exposure and re-injury of the metaplastic epithelium reverses Barrett's esophagus to squamous epithelium as determined by endoscopy and biopsy.

Original languageEnglish (US)
Pages (from-to)532-535
Number of pages4
JournalGastrointestinal Endoscopy
Volume44
Issue number5
DOIs
StatePublished - 1996
Externally publishedYes

Fingerprint

Electrocoagulation
Barrett Esophagus
Acids
Epithelium
Omeprazole
Biopsy
Controlled Environment
Wounds and Injuries
Endoscopy
Adenocarcinoma

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Reversal of Barrett's esophagus with acid suppression and multipolar electrocoagulation : Preliminary results. / Sampliner, R. E.; Fennerty, M (Brian); Garewal, H. S.

In: Gastrointestinal Endoscopy, Vol. 44, No. 5, 1996, p. 532-535.

Research output: Contribution to journalArticle

@article{4cb259c1795e4cf8a1f71b948ea7591a,
title = "Reversal of Barrett's esophagus with acid suppression and multipolar electrocoagulation: Preliminary results",
abstract = "Background: Barrett's esophagus is a premalignant lesion for esophageal adenocarcinoma. This study tests the hypothesis that re-injury of the metaplastic epithelium in an acid-controlled environment will result in reversal of Barrett's to squamous epithelium. Methods: Patients with at least 2 cm of Barrett's esophagus were treated with omeprazole, and half the circumference of the Barrett's was treated with multipolar electrocoagulation (MPEC); the other half served as an internal control. After 6 months, the remaining Barrett's esophagus was treated with MPEC. Results: Twenty-four hour esophageal pH of less than 4 averaged 1.8{\%} on a mean dose of 56 mg/day of omeprazole. Ten patients had visual and biopsy elimination of the targeted section of Barrett's esophagus after an average of 2.5 MPEC sessions. The remainder of the Barrett's esophagus is being treated in 9 patients; currently 5 have no evidence of Barrett's. Conclusions: The combination of control of esophageal acid exposure and re-injury of the metaplastic epithelium reverses Barrett's esophagus to squamous epithelium as determined by endoscopy and biopsy.",
author = "Sampliner, {R. E.} and Fennerty, {M (Brian)} and Garewal, {H. S.}",
year = "1996",
doi = "10.1016/S0016-5107(96)70004-4",
language = "English (US)",
volume = "44",
pages = "532--535",
journal = "Gastrointestinal Endoscopy",
issn = "0016-5107",
publisher = "Mosby Inc.",
number = "5",

}

TY - JOUR

T1 - Reversal of Barrett's esophagus with acid suppression and multipolar electrocoagulation

T2 - Preliminary results

AU - Sampliner, R. E.

AU - Fennerty, M (Brian)

AU - Garewal, H. S.

PY - 1996

Y1 - 1996

N2 - Background: Barrett's esophagus is a premalignant lesion for esophageal adenocarcinoma. This study tests the hypothesis that re-injury of the metaplastic epithelium in an acid-controlled environment will result in reversal of Barrett's to squamous epithelium. Methods: Patients with at least 2 cm of Barrett's esophagus were treated with omeprazole, and half the circumference of the Barrett's was treated with multipolar electrocoagulation (MPEC); the other half served as an internal control. After 6 months, the remaining Barrett's esophagus was treated with MPEC. Results: Twenty-four hour esophageal pH of less than 4 averaged 1.8% on a mean dose of 56 mg/day of omeprazole. Ten patients had visual and biopsy elimination of the targeted section of Barrett's esophagus after an average of 2.5 MPEC sessions. The remainder of the Barrett's esophagus is being treated in 9 patients; currently 5 have no evidence of Barrett's. Conclusions: The combination of control of esophageal acid exposure and re-injury of the metaplastic epithelium reverses Barrett's esophagus to squamous epithelium as determined by endoscopy and biopsy.

AB - Background: Barrett's esophagus is a premalignant lesion for esophageal adenocarcinoma. This study tests the hypothesis that re-injury of the metaplastic epithelium in an acid-controlled environment will result in reversal of Barrett's to squamous epithelium. Methods: Patients with at least 2 cm of Barrett's esophagus were treated with omeprazole, and half the circumference of the Barrett's was treated with multipolar electrocoagulation (MPEC); the other half served as an internal control. After 6 months, the remaining Barrett's esophagus was treated with MPEC. Results: Twenty-four hour esophageal pH of less than 4 averaged 1.8% on a mean dose of 56 mg/day of omeprazole. Ten patients had visual and biopsy elimination of the targeted section of Barrett's esophagus after an average of 2.5 MPEC sessions. The remainder of the Barrett's esophagus is being treated in 9 patients; currently 5 have no evidence of Barrett's. Conclusions: The combination of control of esophageal acid exposure and re-injury of the metaplastic epithelium reverses Barrett's esophagus to squamous epithelium as determined by endoscopy and biopsy.

UR - http://www.scopus.com/inward/record.url?scp=0029855892&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029855892&partnerID=8YFLogxK

U2 - 10.1016/S0016-5107(96)70004-4

DO - 10.1016/S0016-5107(96)70004-4

M3 - Article

C2 - 8934157

AN - SCOPUS:0029855892

VL - 44

SP - 532

EP - 535

JO - Gastrointestinal Endoscopy

JF - Gastrointestinal Endoscopy

SN - 0016-5107

IS - 5

ER -